The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma

Recent molecular classification of glioblastoma (GBM) has shown that patients with a mesenchymal (MES) gene expression signature exhibit poor overall survival and treatment resistance. Using regulatory network analysis of available expression microarray data sets of GBM, including The Cancer Genome...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Bhat, Krishna P.L., Salazar, Katrina L., Balasubramaniyan, Veerakumar, Wani, Khalida, Heathcock, Lindsey, Hollingsworth, Faith, James, Johanna D., Gumin, Joy, Diefes, Kristin L., Kim, Se Hoon, Turski, Alice, Azodi, Yasaman, Yang, Yuhui, Doucette, Tiffany, Colman, Howard, Sulman, Erik P., Lang, Frederick F., Rao, Ganesh, Copray, Sjef, Vaillant, Brian D., Aldape, Kenneth D.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Cold Spring Harbor Laboratory Press 2011
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3248681/
https://ncbi.nlm.nih.gov/pubmed/22190458
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/gad.176800.111
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi